EFFICACY OF PENTASACCHARIDE IN A DOG MODEL OF HEMODIALYSIS
- 15 October 1997
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 88 (2) , 159-170
- https://doi.org/10.1016/s0049-3848(97)00227-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Biochemical and Pharmacological Properties of SANORG 32701Circulation Research, 1996
- Determination of contact phase activation by the measurement of the activity of supernatant and membrane surface-adsorbed factor XII (FXII): Its relevance as a useful parameter for thein vitro assessment of haemodialysis membranesJournal of Biomedical Materials Research, 1996
- Thrombopénie à l'héparine sous hémodialyse en réanimation : utilisation d'un héparinoïde de bas poids moléculaire, l'ORG 10 172 (Orgaran®)Annales Françaises dʼAnesthésie et de Réanimation, 1995
- Pharmacokinetics and Tolerance of the Natural Pentasaccharide (SR90107/ORG31540) with High Affinity to Antithrombin III in ManThrombosis and Haemostasis, 1995
- A comparison between the use of recombinant hirudin and heparin during hemodialysisKidney International, 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- The Adequacy of Fragmin as a Single Bolus Dose with Reused DialyzersArtificial Organs, 1994
- Recombinant hirudin: A specific thrombin inhibiting anticoagulant for hemodialysisKidney International, 1994
- Current trends in the development of anticoagulant and antithrombotic drugsMedical Clinics of North America, 1994
- Low Molecular Weight Heparin (CY-216) versus Unfractionated Heparin in Chronic HemodialysisNephron, 1992